Related Experiment Video
Updated: Jun 25, 2026
06:12
Using Nicotine in a Silica-Exposed Mouse Model to Promote Lung Epithelial-Mesenchymal Transition
Published on: March 3, 2023
[Smoking cessation with nicotine replacement therapy (NRT) - a scientific update]
Karl-Heinz Mulzer1, Alfred Lichtenschopf, Irmgard Homeier
1Johnson & Johnson GmbH, Neuss, Germany.
Wiener Medizinische Wochenschrift (1946)
|February 20, 2009
Summary
Nicotine replacement therapy (NRT) offers various effective forms like gum and patches for tobacco addiction treatment. Evidence supports NRT
Area of Science:
- Pharmacology and Addiction Medicine
- Clinical Therapeutics
Background:
- Tobacco addiction is a significant public health concern.
- Nicotine replacement therapy (NRT) is a widely used cessation aid.
- Various NRT formulations exist, each with unique delivery mechanisms.
Purpose of the Study:
- To evaluate the efficacy and safety of different nicotine replacement therapy (NRT) forms.
- To assess the influence of environmental conditions on NRT effectiveness.
- To provide evidence-based recommendations for NRT selection and usage.
Main Methods:
- Comprehensive review of approximately 132 clinical trials.
- Analysis of efficacy, safety, and environmental factors across NRT types.
- Examination of evidence criteria, including odds ratios (OR).
Main Results:
- NRT forms including nicotine gum, patch, nasal spray, microtab, lozenge, and inhaler demonstrated efficacy.
- Recommended usage based on evidence criteria showed odds ratios ranging from 1.5 to 3.6.
- Most NRT forms are available as over-the-counter (OTC) medicines, with nicotine nasal spray as an exception.
Conclusions:
- Nicotine replacement therapy (NRT) is a proven intervention for tobacco addiction.
- Selection of the appropriate NRT form, dosage, and ensuring user compliance are crucial for treatment success.
- Optimizing NRT use enhances treatment quality and patient outcomes.
Related Concept Videos
01:23Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
01:29Stimulants
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
01:17Drug Dependence
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
01:27CNS Depressants: Alcohol and Nicotine
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...